DPRP inhibitors are a class of chemical compounds specifically designed to inhibit the function of DPRP, which stands for dual-specificity phosphatase-related protein, possibly part of the family of phosphatases involved in regulating phosphorylation events in cells. Phosphatases like DPRP play a critical role in cellular signaling by dephosphorylating serine, threonine, or tyrosine residues on proteins. These phosphorylation and dephosphorylation events act as molecular switches that regulate various cellular functions, such as signal transduction, cell growth, and metabolism. By inhibiting DPRP, researchers can investigate how it modulates these phosphorylation-dependent processes, offering insights into how phosphatases contribute to cellular homeostasis and the balance of kinase-phosphatase activity.
The mechanism of action for DPRP inhibitors generally involves blocking the enzyme's catalytic site, preventing the hydrolysis of phosphate groups from its substrate proteins. These inhibitors may bind to the active site of DPRP, competing with the phosphorylated substrate, or they might interact with allosteric sites, causing conformational changes that inactivate the enzyme. Structurally, DPRP inhibitors are often designed to mimic the phosphorylated state of the target protein, allowing them to bind with high specificity to the phosphatase. Through the use of DPRP inhibitors, researchers can explore how the regulation of phosphorylation states affects intracellular signaling pathways and protein interactions. These inhibitors are essential tools for dissecting the dynamic regulation of cellular processes such as cell division, stress responses, and metabolic pathways, providing a deeper understanding of the role phosphatases like DPRP play in coordinating cellular signaling networks.
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
DNA cross-linking agent disrupting DNA synthesis. It indirectly influences Prl8a2 by affecting cellular processes dependent on intact DNA, impacting the hormone activity and prolactin receptor binding associated with Prl8a2. |